Journal of Young Pharmacists logo
Submit
Journal of Young PharmacistsACADEMIC PUBLISHING
Article

Exploring the Potential of 5-HT1 Receptor Subtypes as Therapeutic Targets for Obesity Treatment in Animal Models

1,2, 1★★ Corresponding author

  1. 1Desh Bhagat University, Mandi Gobindgarh, Punjab, INDIA.
  2. 2G.H.G Khalsa College of Pharmacy, Guruar Sudhar, Punjab, INDIA.

CORRESPONDENCE

Puja Gulati

Desh Bhagat University, Mandi Gobindgarh, Punjab, INDIA.

pujagulati@deshbhagatuniversity.in

Received: 18-10-2024; Revised: 29-12-2024; Accepted: 02-04-2025.

Volume 17, Issue 2 · pp. 353-358 · 2025 · DOI: 10.5530/jyp.20251548

ABSTRACT

Background: Serotonergic system plays an important role in the energy balance evidenced by various studies. The present study was designed to investigate the involvement of 5-HT1 receptor subtype in experimental obesity.Materials and Methods: In the present study effects of chronic administration of eletriptan (2.5 and 10 mg kg-1 day-1, .p.o) specific 5-HT1receptor agonist for 8 weeks along with high fat diet to the obese rats which were pre-treated with high fat diet feeding for 8 weeks on the various parameters of obesity were analysed.Results: Treatment with eletriptan (2.5 and 10 mg kg-1 day-1, .p.o) produced significant dose dependent decrease (p<0.05) in various parameters of obesity as compared to high fat diet group. Eletriptan positively modulate the parameters of obesity. The present data demonstrated that high fat diet induced obesity was prevented by 5-HT receptor agonist eletriptan.Conclusion: Above findings give the strong evidence of involvement of 5-HT1 receptor subtype in obesity.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Kaur, N., & Gulati, P. (2025). Exploring the Potential of 5-HT1 Receptor Subtypes as Therapeutic Targets for Obesity Treatment in Animal Models. Journal of Young Pharmacists, 17(2), 353-358. https://doi.org/10.5530/jyp.20251548

    Copyright and licence

    © 2025 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0